KR101975687B1 - 질병의 치료를 위한, 졸레드론산 또는 관련 화합물의 경구 투여용 조성물 - Google Patents

질병의 치료를 위한, 졸레드론산 또는 관련 화합물의 경구 투여용 조성물 Download PDF

Info

Publication number
KR101975687B1
KR101975687B1 KR1020177013050A KR20177013050A KR101975687B1 KR 101975687 B1 KR101975687 B1 KR 101975687B1 KR 1020177013050 A KR1020177013050 A KR 1020177013050A KR 20177013050 A KR20177013050 A KR 20177013050A KR 101975687 B1 KR101975687 B1 KR 101975687B1
Authority
KR
South Korea
Prior art keywords
zoledronic acid
dosage form
pain
oral dosage
oral
Prior art date
Application number
KR1020177013050A
Other languages
English (en)
Korean (ko)
Other versions
KR20170058444A (ko
Inventor
헤리엇 타부토
Original Assignee
안테씨프 바이오벤쳐스 투 엘엘씨
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US14/063,979 external-priority patent/US8802658B2/en
Application filed by 안테씨프 바이오벤쳐스 투 엘엘씨 filed Critical 안테씨프 바이오벤쳐스 투 엘엘씨
Publication of KR20170058444A publication Critical patent/KR20170058444A/ko
Application granted granted Critical
Publication of KR101975687B1 publication Critical patent/KR101975687B1/ko

Links

Images

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A61K31/675—Phosphorus compounds having nitrogen as a ring hetero atom, e.g. pyridoxal phosphate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pain & Pain Management (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Rheumatology (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Immunology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
KR1020177013050A 2013-10-25 2014-08-08 질병의 치료를 위한, 졸레드론산 또는 관련 화합물의 경구 투여용 조성물 KR101975687B1 (ko)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US14/063,979 US8802658B2 (en) 2012-05-14 2013-10-25 Compositions for oral administration of zoledronic acid or related compounds for treating disease
US14/063,979 2013-10-25
US14/279,241 2014-05-15
US14/279,241 US20140249317A1 (en) 2012-05-14 2014-05-15 Compositions for oral administration of zoledronic acid or related compounds for treating disease
PCT/US2014/050427 WO2015060924A1 (en) 2013-10-25 2014-08-08 Compositions for oral administration of zoledronic acid or related compounds for treating disease

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
KR1020167012645A Division KR101739244B1 (ko) 2013-10-25 2014-08-08 질병의 치료를 위한, 졸레드론산 또는 관련 화합물의 경구 투여용 조성물

Related Child Applications (1)

Application Number Title Priority Date Filing Date
KR1020197001788A Division KR20190009428A (ko) 2013-10-25 2014-08-08 질병의 치료를 위한, 졸레드론산 또는 관련 화합물의 경구 투여용 조성물

Publications (2)

Publication Number Publication Date
KR20170058444A KR20170058444A (ko) 2017-05-26
KR101975687B1 true KR101975687B1 (ko) 2019-05-07

Family

ID=52993341

Family Applications (3)

Application Number Title Priority Date Filing Date
KR1020177013050A KR101975687B1 (ko) 2013-10-25 2014-08-08 질병의 치료를 위한, 졸레드론산 또는 관련 화합물의 경구 투여용 조성물
KR1020167012645A KR101739244B1 (ko) 2013-10-25 2014-08-08 질병의 치료를 위한, 졸레드론산 또는 관련 화합물의 경구 투여용 조성물
KR1020197001788A KR20190009428A (ko) 2013-10-25 2014-08-08 질병의 치료를 위한, 졸레드론산 또는 관련 화합물의 경구 투여용 조성물

Family Applications After (2)

Application Number Title Priority Date Filing Date
KR1020167012645A KR101739244B1 (ko) 2013-10-25 2014-08-08 질병의 치료를 위한, 졸레드론산 또는 관련 화합물의 경구 투여용 조성물
KR1020197001788A KR20190009428A (ko) 2013-10-25 2014-08-08 질병의 치료를 위한, 졸레드론산 또는 관련 화합물의 경구 투여용 조성물

Country Status (12)

Country Link
EP (1) EP3060220A4 (ja)
JP (6) JP6166471B2 (ja)
KR (3) KR101975687B1 (ja)
CN (2) CN108434154A (ja)
AU (2) AU2014340649C1 (ja)
CA (1) CA2928350C (ja)
HK (1) HK1257400A1 (ja)
IL (2) IL245287A0 (ja)
MX (1) MX2016005396A (ja)
MY (1) MY176246A (ja)
SG (3) SG10201800001VA (ja)
WO (1) WO2015060924A1 (ja)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10016445B2 (en) 2012-05-14 2018-07-10 Antecip Bioventures Ii Llc Compositions for oral administration of zoledronic acid or related compounds for treating complex regional pain syndrome
US10413561B2 (en) 2012-05-14 2019-09-17 Antecip Bioventures Ii Llc Neridronic acid and other bisphosphonates for treating complex regional pain syndrome and other diseases
US10493085B2 (en) 2012-05-14 2019-12-03 Antecip Bioventures Ii Llc Neridronic acid and other bisphosphonates for treating complex regional pain syndrome and other diseases
US9956238B2 (en) 2014-05-15 2018-05-01 Antecip Bioventures Ii Llc Compositions for administration of zoledronic acid or related compounds for treating low back pain
US9999629B2 (en) 2012-05-14 2018-06-19 Antecip Bioventures Ii Llc Compositions for oral administration of zoledronic acid or related compounds for treating complex regional pain syndrome
US10350227B2 (en) 2012-05-14 2019-07-16 Antecip Bioventures Ii Llc Neridronic acid for treating complex regional pain syndrome
US11654152B2 (en) 2012-05-14 2023-05-23 Antecip Bioventures Ii Llc Compositions for oral administration of zoledronic acid or related compounds for treating disease
US10413560B2 (en) 2012-05-14 2019-09-17 Antecip Bioventures Ii Llc Dosage forms for oral administration of zoledronic acid or related compounds for treating disease
US10463682B2 (en) 2012-05-14 2019-11-05 Antecip Bioventures Ii Llc Compositions for oral administration of zoledronic acid or related compounds for treating low back pain
CN108434154A (zh) * 2013-10-25 2018-08-24 安泰赛普生物风投二代有限责任公司 用于治疗疾病的唑来膦酸或相关化合物的经口施用组合物
CN109891021B (zh) 2016-10-28 2022-04-12 三菱化学株式会社 碳纤维用上浆剂、碳纤维用上浆剂的水分散液、和附着有上浆剂的碳纤维束

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20050054616A1 (en) * 2003-07-03 2005-03-10 Judith Aronhime Zoledronic acid crystal forms, zoledronate sodium salt crystal forms, amorphous zoledronate sodium salt, and processes for their preparation

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0029111D0 (en) * 2000-11-29 2001-01-10 Novartis Ag Organic compounds
JP2004528340A (ja) * 2001-05-02 2004-09-16 ノバルティス アクチエンゲゼルシャフト ビスホスホネートの医薬的使用
US7875597B2 (en) * 2002-07-24 2011-01-25 New York University Treatment of spinal mechanical pain
AR046773A1 (es) * 2003-12-23 2005-12-21 Novartis Ag Formulaciones farmaceuticas de bisfosfonatos
SI2459176T1 (en) * 2009-07-31 2018-01-31 Gruenenthal Gmbh Crystallization process and bioavailability
LT2531200T (lt) * 2010-02-06 2017-09-25 Grünenthal GmbH Kristalizacijos būdas ir bioprieinamumas
US9340565B2 (en) * 2010-11-24 2016-05-17 Thar Pharmaceuticals, Inc. Crystalline forms
US20130303488A1 (en) * 2012-05-14 2013-11-14 Herriot Tabuteau Compositions Comprising Zoledronic Acid or Related Compounds for Treatment of Complex Regional Pain Syndrome
CN108434154A (zh) * 2013-10-25 2018-08-24 安泰赛普生物风投二代有限责任公司 用于治疗疾病的唑来膦酸或相关化合物的经口施用组合物

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20050054616A1 (en) * 2003-07-03 2005-03-10 Judith Aronhime Zoledronic acid crystal forms, zoledronate sodium salt crystal forms, amorphous zoledronate sodium salt, and processes for their preparation

Also Published As

Publication number Publication date
CA2928350C (en) 2018-01-09
IL254123A0 (en) 2017-10-31
JP6166471B2 (ja) 2017-07-19
EP3060220A1 (en) 2016-08-31
CA2928350A1 (en) 2015-04-30
JP6453387B2 (ja) 2019-01-16
JP2024040304A (ja) 2024-03-25
JP2017200941A (ja) 2017-11-09
CN108434154A (zh) 2018-08-24
HK1257400A1 (zh) 2019-10-18
SG11201603042TA (en) 2016-05-30
KR20170058444A (ko) 2017-05-26
JP2021028343A (ja) 2021-02-25
WO2015060924A1 (en) 2015-04-30
KR101739244B1 (ko) 2017-05-23
SG10201609548UA (en) 2016-12-29
MX2016005396A (es) 2017-03-01
JP2019059771A (ja) 2019-04-18
EP3060220A4 (en) 2017-05-31
CN105960240B (zh) 2018-04-20
AU2014340649B2 (en) 2016-11-17
CN105960240A (zh) 2016-09-21
IL245287A0 (en) 2016-06-30
AU2017200832A1 (en) 2017-03-02
MY176246A (en) 2020-07-24
JP7136487B2 (ja) 2022-09-13
JP2016534081A (ja) 2016-11-04
KR20160062177A (ko) 2016-06-01
AU2014340649C1 (en) 2017-05-18
JP6802245B2 (ja) 2020-12-16
JP2022162105A (ja) 2022-10-21
SG10201800001VA (en) 2018-02-27
KR20190009428A (ko) 2019-01-28

Similar Documents

Publication Publication Date Title
KR101975687B1 (ko) 질병의 치료를 위한, 졸레드론산 또는 관련 화합물의 경구 투여용 조성물
KR20150035597A (ko) 염증성 통증 및 관련 병태의 경감을 위한, 졸레드론산 또는 관련 화합물을 포함하는 조성물
US9616078B2 (en) Dosage forms for oral administration of zoledronic acid or related compounds for treating disease
US9616077B2 (en) Dosage forms for oral administration of zoledronic acid or related compounds for treating disease
AU2014340649A1 (en) Compositions for oral administration of zoledronic acid or related compounds for treating disease
WO2016172453A1 (en) Pharmacodynamic effects after oral administration of zoledronic acid or related compounds

Legal Events

Date Code Title Description
A107 Divisional application of patent
A201 Request for examination
E902 Notification of reason for refusal
AMND Amendment
E601 Decision to refuse application
AMND Amendment
X701 Decision to grant (after re-examination)
GRNT Written decision to grant